Drug Company Will Buy Up to $700 Million in BNB After Coin Hits All-Time High

In brief Nasdaq-listed Windtree Therapeutics has said it will buy up to $700 million in BNB. The company is following software firm Strategy’s gameplan of buying digital assets. A number of publicly traded companies are now buying crypto—and not just Bitcoin—to boost their stock prices. Another day, another crypto treasury. Biotech firm Windtree Therapeutics said...